Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668248 · ClinicalTrials.gov registry record · NA
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
A NA study of Medication Administered in Error and Antipsychotics and Neuroleptics Toxicity, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT04668248 is a NA study of Medication Administered in Error and Antipsychotics and Neuroleptics Toxicity that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 47 participants, below the 877-participant average among 3 other Medication Administered in Error trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04668248, a NA study of Medication Administered in Error and Antipsychotics and Neuroleptics Toxicity, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot project aims to reduce the prescribing of high-risk medications, such as antipsychotics and benzodiazepines, to hospitalized older adults. To accomplish this, this project consists of two phases. The purpose is to determine whether a novel simulation-based training program reduces prescribing of suboptimal medications for older adults. A 2-arm pilot randomized controlled trial will be conducted to test a simulation-based, principle-driven intervention targeting high-risk prescribing practices versus control.
Conditions Studied
Interventions
- OTHER Simulation
- OTHER Online educational training
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668248
The ClinicalTrials.gov registry entry for NCT04668248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 877-participant average among 3 other Medication Administered in Error trials with a reported enrollment target (95% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Medication Administered in Error appearing as the primary indexed condition, and to 2 interventions - of which Simulation is the first listed.
NCT04668248 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04668248 about?
NCT04668248 is a clinical study titled "Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing". This pilot project aims to reduce the prescribing of high-risk medications, such as antipsychotics and benzodiazepines, to hospitalized older adults. To accomplish this, this project consists of two phases. The purpose is to determine whether a novel simulation-based training program reduces prescri...
What is the current status of trial NCT04668248?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2021-03-29. Estimated completion is 2021-12-31.
What conditions does trial NCT04668248 study?
This clinical trial studies the following conditions: Medication Administered in Error, Antipsychotics and Neuroleptics Toxicity.
What interventions are being tested in trial NCT04668248?
The interventions under investigation include: Simulation (OTHER), Online educational training (OTHER).
Who is sponsoring clinical trial NCT04668248?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04668248 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Administered in Error
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Medication Administered in Error
All registered trials for this condition
Antipsychotics and Neuroleptics Toxicity
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.